IMMEDIATE-RELEASE NIFEDIPINE LABELING WILL WARN AGAINST OFF-LABEL USES, FDA INDICATES FOLLOWING CALCIUM CHANNEL BLOCKER ADVISORY COMMITTEE REVIEW

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".